News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Crypto Assets Investors Cryptocurrency Shares Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Etf Stablecoin Sec Eth Trade Bse Index Earnings Ipo Revenue Solana China Coinbase Token Inflation Wall Street Nasdaq Interest Rates Sensex Trade War Usd Economy Tesla Nse Profit Traders Gold Digital Assets Bse Sensex Sp 500 Treasury Federal Reserve Remuneration Organized Crime Astra Microwave Mezo Eof Diversifying Cash Instruments Bitumen Copd Hashdex

Filter by:

Past 24 hours
Past week
Past month
Past year

ABC News Business
BBC Business
Business Insider Markets
CBC Business
City A.M.
CNBC Business
CoinDesk
Cointelegraph
Crypto News
CryptoSlate
Decrypt
Economic Times Markets
Euronews Business
Financial Post Top Stories
Financial Times
Finextra Crypto
Finextra Market
Finextra Wealth
Globe and Mail Investing
Investing.com Global Markets
Investing.com Global Mkts
Investopedia
Kiplinger
MarketWatch MarketPulse
MarketWatch Top Stories
Quartz
Sky News Money
Sydney Morning Herald Biz
Sydney Morning Herald Business
TechCrunch Fintech
The Block
The Guardian – Business
WSJ Markets News

Merck × Past week × CNBC Business ×

CNBC Business • Jun 09, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...

Read Full Article →